Pharm

Marketers Trend Report 2018: Relief after one year of Trump doesn't mitigate all concerns

Marketers Trend Report 2018: Relief after one year of Trump doesn't mitigate all concerns

By

The general sense: Nobody should get comfortable with the status quo

GSK prepares for Advair competition

GSK prepares for Advair competition

By

If generic versions by Mylan, Hikma, and Vectura are approved mid-year, GSK expects sales of Advair to be flat or decline.